Found: 33
Select item for more details and to access through your institution.
Marqibo (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 555, doi. 10.1007/s00280-012-2042-4
- By:
- Publication type:
- Article
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 565, doi. 10.1007/s00280-012-2030-8
- By:
- Publication type:
- Article
Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 575, doi. 10.1007/s00280-012-2031-7
- By:
- Publication type:
- Article
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 581, doi. 10.1007/s00280-012-2033-5
- By:
- Publication type:
- Article
The use of the (13)C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The use of the C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 593, doi. 10.1007/s00280-012-2034-4
- By:
- Publication type:
- Article
Erratum to: The use of the C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 605, doi. 10.1007/s00280-012-2037-1
- By:
- Publication type:
- Article
Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 613, doi. 10.1007/s00280-012-2044-2
- By:
- Publication type:
- Article
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 619, doi. 10.1007/s00280-012-2047-z
- By:
- Publication type:
- Article
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 627, doi. 10.1007/s00280-012-2048-y
- By:
- Publication type:
- Article
Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 635, doi. 10.1007/s00280-012-2050-4
- By:
- Publication type:
- Article
Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 647, doi. 10.1007/s00280-012-2051-3
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 657, doi. 10.1007/s00280-012-2052-2
- By:
- Publication type:
- Article
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 663, doi. 10.1007/s00280-012-2055-z
- By:
- Publication type:
- Article
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 671, doi. 10.1007/s00280-012-2056-y
- By:
- Publication type:
- Article
Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 681, doi. 10.1007/s00280-012-2058-9
- By:
- Publication type:
- Article
Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 693, doi. 10.1007/s00280-012-2060-2
- By:
- Publication type:
- Article
Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 705, doi. 10.1007/s00280-012-2061-1
- By:
- Publication type:
- Article
(−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 713, doi. 10.1007/s00280-012-2063-z
- By:
- Publication type:
- Article
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1[alpha].
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 727, doi. 10.1007/s00280-012-2066-9
- By:
- Publication type:
- Article
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 733, doi. 10.1007/s00280-012-2067-8
- By:
- Publication type:
- Article
Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 741, doi. 10.1007/s00280-012-2068-7
- By:
- Publication type:
- Article
Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 749, doi. 10.1007/s00280-013-2069-1
- By:
- Publication type:
- Article
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 765, doi. 10.1007/s00280-013-2070-8
- By:
- Publication type:
- Article
p75NTR: an enhancer of fenretinide toxicity in neuroblastoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 777, doi. 10.1007/s00280-013-2071-7
- By:
- Publication type:
- Article
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 789, doi. 10.1007/s00280-013-2073-5
- By:
- Publication type:
- Article
Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 799, doi. 10.1007/s00280-013-2074-4
- By:
- Publication type:
- Article
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 809, doi. 10.1007/s00280-012-2049-x
- By:
- Publication type:
- Article
Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 817, doi. 10.1007/s00280-012-2054-0
- By:
- Publication type:
- Article
Immunohistochemical study of MRP5 expression in meningiomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 825, doi. 10.1007/s00280-012-2057-x
- By:
- Publication type:
- Article